Navigation Links
Amgen's Breakaway from Cancer Initiative Expands to Help Cancer Patients Access Broad Spectrum of Cancer Resources and Services
Date:1/22/2009

mgen.com/" target="_new">www.amgen.com.

About the Lance Armstrong Foundation

At the Lance Armstrong Foundation, we fight for the 28 million people around the world living with cancer today. There can be - and should be - life after cancer for more people. That's why we kick in at the moment of diagnosis, giving people the resources and support they need to fight cancer head-on. We find innovative ways to raise awareness, fund research and end the stigma about cancer that many survivors face. We connect people and communities to drive social change, and we call for state, national and world leaders to help fight this disease. Anyone, anywhere can join our fight against cancer. Join us at LIVESTRONG.org.

About the National Coalition for Cancer Survivorship

The National Coalition for Cancer Survivorship (NCCS) is a leading cancer advocacy organization founded by and for cancer survivors more than 20 years ago. Its priorities are to advocate for quality cancer care for all Americans and to empower people with cancer to advocate for themselves. Believing that access to credible and accurate patient information is fundamental to understanding and receiving quality cancer care, NCCS provides tools and information for people to become strong advocates for their own care or the care of others. The award-winning Cancer Survival Toolbox(R) and other resources and information are available at www.canceradvocacy.org or 301-650-9127.

About Patient Advocate Foundation

Patient Advocate Foundation (PAF) was established in 1996 as a national 501(c)3 organization with a mission of safeguarding patients with chronic, life threatening, and/or debilitating illnesses assuring access to care, maintenance of employment and preservation of their financial stability. Through this work, its patients
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Johns Hopkins to add Elekta Synergy S(R) to Cancer Treatment Lineup
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. Novel Technology Breaks Through Cancer Pain
9. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
10. Pharmion and MethylGene Announce Collaboration to Develop Sirtuin Inhibitors as Anti-Cancer Agents
11. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... November 20, 2014 Author Matthew J. ... to the Other Side” published as a tribute ... in the “Fiction: Short Story” category of the ... President and CEO of USA Book News, said this ... independent publishers, including Simon & Schuster, Penguin, John Wiley ...
(Date:11/21/2014)... New York, NY (PRWEB) November 20, 2014 ... ) is now available as an open access journal ... cells with infrared fluorescent proteins to preserve photoresponsiveness in ... Two-color fluorescent in situ hybridization using chromogenic ... microfluidics chips for DNA, RNA, and protein electrophoresis , ...
(Date:11/21/2014)... 2014 Deep Research Report on Global ... and in-depth research report on the Sodium ferrocyanide ... its definition, classification, application, and industry chain structure ... the international market analysis, including China’s domestic market ... Europe, Asia, China, Japan etc. regions) industry analysis ...
(Date:11/21/2014)... - Aequus Pharmaceuticals Inc. (the "Company" or "Aequus") ... a brokered private placement offering (the "Brokered Offering") ... Securities Inc. and Clarus Securities Inc. acted as ... syndicate of agents that also included Wolverton Securities ... Concurrently with the Brokered Offering, the Company also ...
Breaking Biology Technology:Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 2Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 3Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 4BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 2BioTechniques: The International Journal of Life Science Methods Announces the Publication of the November 2014 Issue—Available in Print and Online 3Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Aequus Pharmaceuticals closes $4.2 million private placement financing 2Aequus Pharmaceuticals closes $4.2 million private placement financing 3
... on VeraTag(TM) technology,s ability to ... predict response to Herceptin(R), SOUTH ... MGRM ) today announced that scientific,collaborators will present results on ... HER2 and predict response to,Herceptin(R) (trastuzumab) in patients with metastatic ...
... scale back commitment to ... ... symbol: SBS, CALGARY, May 16 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc.,(TSX:SBS), ... cardiovascular diseases, today announced that,its joint development partner on the ImmunoSphere(TM) ...
... Corporation,announced today that it has enrolled and ... IIb trial with oral larazotide acetate, an ... of patients with active,celiac disease (CD). The ... the clinical and histological,efficacy, safety and tolerability ...
Cached Biology Technology:Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting 2Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting 3Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting 4Monogram Announces HERmark(TM) Oral Presentation at the 44th ASCO Annual Meeting 5SemBioSys provides update on shrimp feed additive, Immunosphere(TM) 2SemBioSys provides update on shrimp feed additive, Immunosphere(TM) 3Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 2Alba Therapeutics Announces the Enrollment and Randomization of the First Patient in the Phase IIb Clinical Trial for Larazotide Acetate (AT-1001) for the Treatment of Active Celiac Disease 3
(Date:11/12/2014)... GARDENS, Fla. , Nov. 12, 2014 ... announced today that its U.are.U ® fingerprint readers ... bakery chain in Central Mexico . ... June 2014 to eliminate payroll issues caused by employees ... to installing the U.are.U fingerprint readers, Montparnasse relied on ...
(Date:11/7/2014)... Dr. Debra Auguste, associate professor, biomedical engineering, in ... College of New York, have identified a molecule ... of the most aggressive forms of breast cancer. ... high mortality rate owing to aggressive proliferation and ... However, Professor Auguste,s team, discovered the overexpression of ...
(Date:11/6/2014)... paper from a team of Florida State University biologists ... could adapt to and survive environmental swings such as ... latest issue of the journal The Plant Cell ... DNA and proteins) is organized in a cell and ... are turned on and others are turned off. , ...
Breaking Biology News(10 mins):Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2Maize analysis yields whole new world of genetic science 2
... Deutsches rzteblatt International (Dtsch Arztebl Int 2010; 107[31-32]: ... the PRISCUS List: a list of medications that carry ... elderly patients. The authors present the new list, ... of a joint project entitled PRISCUS (Latin for "old ...
... Ariz. Arizona State University researchers have demonstrated a ... and unhealthy protein levels. New testing instrumentation ... make the procedure less costly and produce results in ... because of the complications of working with blood, saliva, ...
... ,Genes reside along long chains of DNA ... a gene on the sex chromosome X may enhance an ... Systemic lupus erythematosus (SLE) is an autoimmune disease that ... occurred in a gene on the X, or female, chromosome, ...
Cached Biology News:Health diagnosis made simpler 2Health diagnosis made simpler 3Health diagnosis made simpler 4
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
Human acetylcholine receptor (AChR)-alpha. Exhibits homogenous, high affinity,binding to the receptor. Binds weakly to a64-78. Inhibits binding of many,myasthenia gravis sera to human AChR....
Dnase and Rnase free...
...
Biology Products: